APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Neurotrophins

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Neurotrophins Market Analysis and Forecast 2026-2032

Report ID 174016710219 December 2025195 pages

Choose your research edition.

Industry ResearchNeurotrophins Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurotrophins Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Neurotrophins Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurotrophins Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurotrophins Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Neurotrophins market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Neurotrophins is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Neurotrophins is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Neurotrophins is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Neurotrophins is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Neurotrophins include FibroGen, GE Healthcare, Merck Serono, PeproTech, Scil Proteins GmbH, Scil Proteins GmbH, Lonza Groups and Johnson＆Johnson, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Neurotrophins, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Neurotrophins, also provides the sales of main regions and countries. Of the upcoming market potential for Neurotrophins, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Neurotrophins sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Neurotrophins market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Neurotrophins sales, projected growth trends, production technology, application and end-user industry.

Neurotrophins Segment by Company

FibroGen

GE Healthcare

Merck Serono

PeproTech

Scil Proteins GmbH

Scil Proteins GmbH

Lonza Groups

Johnson＆Johnson

Neurotrophins Segment by Type

Dehydroepiandrosterone Sulfate

Brain-Derived Neurotrophic Factor

Nerve Growth Factor

Other

Neurotrophins Segment by Application

Alzheimer'S Disease

Amyotrophic Lateral Sclerosis

Parkinson'S Disease

Other

Neurotrophins Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurotrophins market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurotrophins and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurotrophins.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Neurotrophins in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Neurotrophins manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neurotrophins sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Neurotrophins Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Dehydroepiandrosterone Sulfate Major Manufacturers Table 3. Brain-Derived Neurotrophic Factor Major Manufacturers Table 4. Nerve Growth Factor Major Manufacturers Table 5. Other Major Manufacturers Table 6. Global Neurotrophins Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Alzheimer'S Disease Major Manufacturers Table 8. Amyotrophic Lateral Sclerosis Major Manufacturers Table 9. Parkinson'S Disease Major Manufacturers Table 10. Other Major Manufacturers Table 11. Neurotrophins Industry Trends Table 12. Neurotrophins Industry Drivers Table 13. Neurotrophins Industry Opportunities and Challenges Table 14. Neurotrophins Industry Restraints Table 15. Global Neurotrophins Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Neurotrophins Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Neurotrophins Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Neurotrophins Revenue Market Share by Region (2021-2026) Table 19. Global Neurotrophins Revenue Market Share by Region (2027-2032) Table 20. Global Neurotrophins Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global Neurotrophins Sales by Region (2021-2026) & (K Units) Table 22. Global Neurotrophins Sales by Region (2027-2032) & (K Units) Table 23. Global Neurotrophins Sales Market Share by Region (2021-2026) Table 24. Global Neurotrophins Sales Market Share by Region (2027-2032) Table 25. Global Neurotrophins Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Neurotrophins Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Neurotrophins Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Neurotrophins Sales Market Share by Manufacturers (2021-2026) Table 29. Global Neurotrophins Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Neurotrophins Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Neurotrophins Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Neurotrophins Manufacturers, Product Type & Application Table 33. Global Neurotrophins Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Neurotrophins by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Neurotrophins Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Neurotrophins Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Neurotrophins Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Neurotrophins Revenue Market Share by Type (2021-2026) Table 40. Global Neurotrophins Revenue Market Share by Type (2027-2032) Table 41. Global Neurotrophins Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global Neurotrophins Sales by Type (2021-2026) & (K Units) Table 43. Global Neurotrophins Sales by Type (2027-2032) & (K Units) Table 44. Global Neurotrophins Sales Market Share by Type (2021-2026) Table 45. Global Neurotrophins Sales Market Share by Type (2027-2032) Table 46. Global Neurotrophins Price by Type (2021-2026) & (US$/Unit) Table 47. Global Neurotrophins Price by Type (2027-2032) & (US$/Unit) Table 48. Global Neurotrophins Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Neurotrophins Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Neurotrophins Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Neurotrophins Revenue Market Share by Application (2021-2026) Table 52. Global Neurotrophins Revenue Market Share by Application (2027-2032) Table 53. Global Neurotrophins Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global Neurotrophins Sales by Application (2021-2026) & (K Units) Table 55. Global Neurotrophins Sales by Application (2027-2032) & (K Units) Table 56. Global Neurotrophins Sales Market Share by Application (2021-2026) Table 57. Global Neurotrophins Sales Market Share by Application (2027-2032) Table 58. Global Neurotrophins Price by Application (2021-2026) & (US$/Unit) Table 59. Global Neurotrophins Price by Application (2027-2032) & (US$/Unit) Table 60. FibroGen Company Information Table 61. FibroGen Business Overview Table 62. FibroGen Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. FibroGen Neurotrophins Product Portfolio Table 64. FibroGen Recent Development Table 65. GE Healthcare Company Information Table 66. GE Healthcare Business Overview Table 67. GE Healthcare Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. GE Healthcare Neurotrophins Product Portfolio Table 69. GE Healthcare Recent Development Table 70. Merck Serono Company Information Table 71. Merck Serono Business Overview Table 72. Merck Serono Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Merck Serono Neurotrophins Product Portfolio Table 74. Merck Serono Recent Development Table 75. PeproTech Company Information Table 76. PeproTech Business Overview Table 77. PeproTech Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. PeproTech Neurotrophins Product Portfolio Table 79. PeproTech Recent Development Table 80. Scil Proteins GmbH Company Information Table 81. Scil Proteins GmbH Business Overview Table 82. Scil Proteins GmbH Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Scil Proteins GmbH Neurotrophins Product Portfolio Table 84. Scil Proteins GmbH Recent Development Table 85. Scil Proteins GmbH Company Information Table 86. Scil Proteins GmbH Business Overview Table 87. Scil Proteins GmbH Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Scil Proteins GmbH Neurotrophins Product Portfolio Table 89. Scil Proteins GmbH Recent Development Table 90. Lonza Groups Company Information Table 91. Lonza Groups Business Overview Table 92. Lonza Groups Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Lonza Groups Neurotrophins Product Portfolio Table 94. Lonza Groups Recent Development Table 95. Johnson＆Johnson Company Information Table 96. Johnson＆Johnson Business Overview Table 97. Johnson＆Johnson Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Johnson＆Johnson Neurotrophins Product Portfolio Table 99. Johnson＆Johnson Recent Development Table 100. North America Neurotrophins Revenue by Type (2021-2026) & (US$ Million) Table 101. North America Neurotrophins Revenue by Type (2027-2032) & (US$ Million) Table 102. North America Neurotrophins Sales by Type (2021-2026) & (K Units) Table 103. North America Neurotrophins Sales by Type (2027-2032) & (K Units) Table 104. North America Neurotrophins Sales Price by Type (2021-2026) & (US$/Unit) Table 105. North America Neurotrophins Sales Price by Type (2027-2032) & (US$/Unit) Table 106. North America Neurotrophins Revenue by Application (2021-2026) & (US$ Million) Table 107. North America Neurotrophins Revenue by Application (2027-2032) & (US$ Million) Table 108. North America Neurotrophins Sales by Application (2021-2026) & (K Units) Table 109. North America Neurotrophins Sales by Application (2027-2032) & (K Units) Table 110. North America Neurotrophins Sales Price by Application (2021-2026) & (US$/Unit) Table 111. North America Neurotrophins Sales Price by Application (2027-2032) & (US$/Unit) Table 112. North America Neurotrophins Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. North America Neurotrophins Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 114. North America Neurotrophins Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 115. North America Neurotrophins Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 116. North America Neurotrophins Sales by Country (2021-2026) & (K Units) Table 117. North America Neurotrophins Sales by Country (2027-2032) & (K Units) Table 118. North America Neurotrophins Sales Price by Country (2021-2026) & (US$/Unit) Table 119. North America Neurotrophins Sales Price by Country (2027-2032) & (US$/Unit) Table 120. United States Neurotrophins Revenue (2021-2032) & (US$ Million) Table 121. Canada Neurotrophins Revenue (2021-2032) & (US$ Million) Table 122. Europe Neurotrophins Revenue by Type (2021-2026) & (US$ Million) Table 123. Europe Neurotrophins Revenue by Type (2027-2032) & (US$ Million) Table 124. Europe Neurotrophins Sales by Type (2021-2026) & (K Units) Table 125. Europe Neurotrophins Sales by Type (2027-2032) & (K Units) Table 126. Europe Neurotrophins Sales Price by Type (2021-2026) & (US$/Unit) Table 127. Europe Neurotrophins Sales Price by Type (2027-2032) & (US$/Unit) Table 128. Europe Neurotrophins Revenue by Application (2021-2026) & (US$ Million) Table 129. Europe Neurotrophins Revenue by Application (2027-2032) & (US$ Million) Table 130. Europe Neurotrophins Sales by Application (2021-2026) & (K Units) Table 131. Europe Neurotrophins Sales by Application (2027-2032) & (K Units) Table 132. Europe Neurotrophins Sales Price by Application (2021-2026) & (US$/Unit) Table 133. Europe Neurotrophins Sales Price by Application (2027-2032) & (US$/Unit) Table 134. Europe Neurotrophins Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Europe Neurotrophins Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 136. Europe Neurotrophins Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 137. Europe Neurotrophins Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 138. Europe Neurotrophins Sales by Country (2021-2026) & (K Units) Table 139. Europe Neurotrophins Sales by Country (2027-2032) & (K Units) Table 140. Europe Neurotrophins Sales Price by Country (2021-2026) & (US$/Unit) Table 141. Europe Neurotrophins Sales Price by Country (2027-2032) & (US$/Unit) Table 142. Germany Neurotrophins Revenue (2021-2032) & (US$ Million) Table 143. France Neurotrophins Revenue (2021-2032) & (US$ Million) Table 144. U.K. Neurotrophins Revenue (2021-2032) & (US$ Million) Table 145. Italy Neurotrophins Revenue (2021-2032) & (US$ Million) Table 146. Netherlands Neurotrophins Revenue (2021-2032) & (US$ Million) Table 147. China Neurotrophins Revenue by Type (2021-2026) & (US$ Million) Table 148. China Neurotrophins Revenue by Type (2027-2032) & (US$ Million) Table 149. China Neurotrophins Sales by Type (2021-2026) & (K Units) Table 150. China Neurotrophins Sales by Type (2027-2032) & (K Units) Table 151. China Neurotrophins Sales Price by Type (2021-2026) & (US$/Unit) Table 152. China Neurotrophins Sales Price by Type (2027-2032) & (US$/Unit) Table 153. China Neurotrophins Revenue by Application (2021-2026) & (US$ Million) Table 154. China Neurotrophins Revenue by Application (2027-2032) & (US$ Million) Table 155. China Neurotrophins Sales by Application (2021-2026) & (K Units) Table 156. China Neurotrophins Sales by Application (2027-2032) & (K Units) Table 157. China Neurotrophins Sales Price by Application (2021-2026) & (US$/Unit) Table 158. China Neurotrophins Sales Price by Application (2027-2032) & (US$/Unit) Table 159. Asia Neurotrophins Revenue by Type (2021-2026) & (US$ Million) Table 160. Asia Neurotrophins Revenue by Type (2027-2032) & (US$ Million) Table 161. Asia Neurotrophins Sales by Type (2021-2026) & (K Units) Table 162. Asia Neurotrophins Sales by Type (2027-2032) & (K Units) Table 163. Asia Neurotrophins Sales Price by Type (2021-2026) & (US$/Unit) Table 164. Asia Neurotrophins Sales Price by Type (2027-2032) & (US$/Unit) Table 165. Asia Neurotrophins Revenue by Application (2021-2026) & (US$ Million) Table 166. Asia Neurotrophins Revenue by Application (2027-2032) & (US$ Million) Table 167. Asia Neurotrophins Sales by Application (2021-2026) & (K Units) Table 168. Asia Neurotrophins Sales by Application (2027-2032) & (K Units) Table 169. Asia Neurotrophins Sales Price by Application (2021-2026) & (US$/Unit) Table 170. Asia Neurotrophins Sales Price by Application (2027-2032) & (US$/Unit) Table 171. Asia Neurotrophins Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. Asia Neurotrophins Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 173. Asia Neurotrophins Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 174. Asia Neurotrophins Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 175. Asia Neurotrophins Sales by Country (2021-2026) & (K Units) Table 176. Asia Neurotrophins Sales by Country (2027-2032) & (K Units) Table 177. Asia Neurotrophins Sales Price by Country (2021-2026) & (US$/Unit) Table 178. Asia Neurotrophins Sales Price by Country (2027-2032) & (US$/Unit) Table 179. Japan Neurotrophins Revenue (2021-2032) & (US$ Million) Table 180. South Korea Neurotrophins Revenue (2021-2032) & (US$ Million) Table 181. India Neurotrophins Revenue (2021-2032) & (US$ Million) Table 182. Australia Neurotrophins Revenue (2021-2032) & (US$ Million) Table 183. China Taiwan Neurotrophins Revenue (2021-2032) & (US$ Million) Table 184. Southeast Asia Neurotrophins Revenue (2021-2032) & (US$ Million) Table 185. SAMEA Neurotrophins Revenue by Type (2021-2026) & (US$ Million) Table 186. SAMEA Neurotrophins Revenue by Type (2027-2032) & (US$ Million) Table 187. SAMEA Neurotrophins Sales by Type (2021-2026) & (K Units) Table 188. SAMEA Neurotrophins Sales by Type (2027-2032) & (K Units) Table 189. SAMEA Neurotrophins Sales Price by Type (2021-2026) & (US$/Unit) Table 190. SAMEA Neurotrophins Sales Price by Type (2027-2032) & (US$/Unit) Table 191. SAMEA Neurotrophins Revenue by Application (2021-2026) & (US$ Million) Table 192. SAMEA Neurotrophins Revenue by Application (2027-2032) & (US$ Million) Table 193. SAMEA Neurotrophins Sales by Application (2021-2026) & (K Units) Table 194. SAMEA Neurotrophins Sales by Application (2027-2032) & (K Units) Table 195. SAMEA Neurotrophins Sales Price by Application (2021-2026) & (US$/Unit) Table 196. SAMEA Neurotrophins Sales Price by Application (2027-2032) & (US$/Unit) Table 197. SAMEA Neurotrophins Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 198. SAMEA Neurotrophins Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 199. SAMEA Neurotrophins Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 200. SAMEA Neurotrophins Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 201. SAMEA Neurotrophins Sales by Country (2021-2026) & (K Units) Table 202. SAMEA Neurotrophins Sales by Country (2027-2032) & (K Units) Table 203. SAMEA Neurotrophins Sales Price by Country (2021-2026) & (US$/Unit) Table 204. SAMEA Neurotrophins Sales Price by Country (2027-2032) & (US$/Unit) Table 205. Brazil Neurotrophins Revenue (2021-2032) & (US$ Million) Table 206. Argentina Neurotrophins Revenue (2021-2032) & (US$ Million) Table 207. Chile Neurotrophins Revenue (2021-2032) & (US$ Million) Table 208. Colombia Neurotrophins Revenue (2021-2032) & (US$ Million) Table 209. Peru Neurotrophins Revenue (2021-2032) & (US$ Million) Table 210. Saudi Arabia Neurotrophins Revenue (2021-2032) & (US$ Million) Table 211. Israel Neurotrophins Revenue (2021-2032) & (US$ Million) Table 212. UAE Neurotrophins Revenue (2021-2032) & (US$ Million) Table 213. Turkey Neurotrophins Revenue (2021-2032) & (US$ Million) Table 214. Iran Neurotrophins Revenue (2021-2032) & (US$ Million) Table 215. Egypt Neurotrophins Revenue (2021-2032) & (US$ Million) Table 216. Key Raw Materials Table 217. Raw Materials Key Suppliers Table 218. Neurotrophins Distributors List Table 219. Neurotrophins Customers List Table 220. Research Programs/Design for This Report Table 221. Authors List of This Report Table 222. Secondary Sources Table 223. Primary Sources List of Figures Figure 1. Neurotrophins Image Figure 2. Global Neurotrophins Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neurotrophins Market Size Share 2021 VS 2025 VS 2032 Figure 4. Dehydroepiandrosterone Sulfate Image Figure 5. Brain-Derived Neurotrophic Factor Image Figure 6. Nerve Growth Factor Image Figure 7. Other Image Figure 8. Global Neurotrophins Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Neurotrophins Market Size Share 2021 VS 2025 VS 2032 Figure 10. Alzheimer'S Disease Image Figure 11. Amyotrophic Lateral Sclerosis Image Figure 12. Parkinson'S Disease Image Figure 13. Other Image Figure 14. Global Neurotrophins Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Neurotrophins Revenue (2021-2032) & (US$ Million) Figure 16. Global Neurotrophins Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Neurotrophins Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Neurotrophins Revenue Market Share by Region (2021-2032) Figure 19. Global Neurotrophins Sales (2021-2032) & (K Units) Figure 20. Global Neurotrophins Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global Neurotrophins Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Neurotrophins Sales YoY (2021-2032) & (K Units) Figure 23. Europe Neurotrophins Sales YoY (2021-2032) & (K Units) Figure 24. China Neurotrophins Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) Neurotrophins Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa Neurotrophins Sales YoY (2021-2032) & (K Units) Figure 27. Global Neurotrophins Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Neurotrophins Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Neurotrophins Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Neurotrophins Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Neurotrophins Revenue Market Share by Type (2021-2032) Figure 33. Global Neurotrophins Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global Neurotrophins Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Neurotrophins Sales Market Share by Type (2021-2032) Figure 36. Global Neurotrophins Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Neurotrophins Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Neurotrophins Revenue Market Share by Application (2021-2032) Figure 39. Global Neurotrophins Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global Neurotrophins Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Neurotrophins Sales Market Share by Application (2021-2032) Figure 42. North America Neurotrophins Revenue Share by Type (2021-2032) Figure 43. North America Neurotrophins Sales Share by Type (2021-2032) Figure 44. North America Neurotrophins Revenue Share by Application (2021-2032) Figure 45. North America Neurotrophins Sales Share by Application (2021-2032) Figure 46. North America Neurotrophins Revenue Share by Country (2021-2032) Figure 47. North America Neurotrophins Sales Share by Country (2021-2032) Figure 48. Europe Neurotrophins Revenue Share by Type (2021-2032) Figure 49. Europe Neurotrophins Sales Share by Type (2021-2032) Figure 50. Europe Neurotrophins Revenue Share by Application (2021-2032) Figure 51. Europe Neurotrophins Sales Share by Application (2021-2032) Figure 52. Europe Neurotrophins Revenue Share by Country (2021-2032) Figure 53. Europe Neurotrophins Sales Share by Country (2021-2032) Figure 54. China Neurotrophins Revenue Share by Type (2021-2032) Figure 55. China Neurotrophins Sales Share by Type (2021-2032) Figure 56. China Neurotrophins Revenue Share by Application (2021-2032) Figure 57. China Neurotrophins Sales Share by Application (2021-2032) Figure 58. Asia Neurotrophins Revenue Share by Type (2021-2032) Figure 59. Asia Neurotrophins Sales Share by Type (2021-2032) Figure 60. Asia Neurotrophins Revenue Share by Application (2021-2032) Figure 61. Asia Neurotrophins Sales Share by Application (2021-2032) Figure 62. Asia Neurotrophins Revenue Share by Country (2021-2032) Figure 63. Asia Neurotrophins Sales Share by Country (2021-2032) Figure 64. SAMEA Neurotrophins Revenue Share by Type (2021-2032) Figure 65. SAMEA Neurotrophins Sales Share by Type (2021-2032) Figure 66. SAMEA Neurotrophins Revenue Share by Application (2021-2032) Figure 67. SAMEA Neurotrophins Sales Share by Application (2021-2032) Figure 68. SAMEA Neurotrophins Revenue Share by Country (2021-2032) Figure 69. SAMEA Neurotrophins Sales Share by Country (2021-2032) Figure 70. Neurotrophins Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Neurotrophins Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Dehydroepiandrosterone Sulfate
  • Brain-Derived Neurotrophic Factor
  • Nerve Growth Factor
  • Other
Applications
  • Alzheimer'S Disease
  • Amyotrophic Lateral Sclerosis
  • Parkinson'S Disease
  • Other
Companies covered
  • FibroGen
  • GE Healthcare
  • Merck Serono
  • PeproTech
  • Scil Proteins GmbH
  • Scil Proteins GmbH
  • Lonza Groups
  • Johnson＆Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Neurotrophins Market by Type
  3. 1.2.1 Global Neurotrophins Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Dehydroepiandrosterone Sulfate
  5. 1.2.3 Brain-Derived Neurotrophic Factor
  6. 1.2.4 Nerve Growth Factor
  7. 1.2.5 Other
  8. 1.3 Neurotrophins Market by Application
  9. 1.3.1 Global Neurotrophins Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Alzheimer'S Disease
  11. 1.3.3 Amyotrophic Lateral Sclerosis
  12. 1.3.4 Parkinson'S Disease
  13. 1.3.5 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Neurotrophins Market Dynamics
  1. 2.1 Neurotrophins Industry Trends
  2. 2.2 Neurotrophins Industry Drivers
  3. 2.3 Neurotrophins Industry Opportunities and Challenges
  4. 2.4 Neurotrophins Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Neurotrophins Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Neurotrophins Revenue by Region
  3. 3.2.1 Global Neurotrophins Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Neurotrophins Revenue by Region (2021-2026)
  5. 3.2.3 Global Neurotrophins Revenue by Region (2027-2032)
  6. 3.2.4 Global Neurotrophins Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Neurotrophins Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Neurotrophins Sales by Region
  9. 3.4.1 Global Neurotrophins Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Neurotrophins Sales by Region (2021-2026)
  11. 3.4.3 Global Neurotrophins Sales by Region (2027-2032)
  12. 3.4.4 Global Neurotrophins Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Neurotrophins Revenue by Manufacturers
  2. 4.1.1 Global Neurotrophins Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Neurotrophins Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Neurotrophins Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Neurotrophins Sales by Manufacturers
  6. 4.2.1 Global Neurotrophins Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Neurotrophins Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Neurotrophins Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Neurotrophins Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Neurotrophins Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Neurotrophins Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Neurotrophins Manufacturers, Product Type & Application
  13. 4.7 Global Neurotrophins Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Neurotrophins Market CR5 and HHI
  16. 4.8.2 2025 Neurotrophins Tier 1, Tier 2, and Tier 3
5 Neurotrophins Market by Type
  1. 5.1 Global Neurotrophins Revenue by Type
  2. 5.1.1 Global Neurotrophins Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Neurotrophins Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Neurotrophins Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Neurotrophins Sales by Type
  6. 5.2.1 Global Neurotrophins Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Neurotrophins Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Neurotrophins Sales Market Share by Type (2021-2032)
  9. 5.3 Global Neurotrophins Price by Type
6 Neurotrophins Market by Application
  1. 6.1 Global Neurotrophins Revenue by Application
  2. 6.1.1 Global Neurotrophins Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Neurotrophins Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Neurotrophins Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Neurotrophins Sales by Application
  6. 6.2.1 Global Neurotrophins Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Neurotrophins Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Neurotrophins Sales Market Share by Application (2021-2032)
  9. 6.3 Global Neurotrophins Price by Application
7 Company Profiles
  1. 7.1 FibroGen
  2. 7.1.1 FibroGen Company Information
  3. 7.1.2 FibroGen Business Overview
  4. 7.1.3 FibroGen Neurotrophins Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 FibroGen Neurotrophins Product Portfolio
  6. 7.1.5 FibroGen Recent Developments
  7. 7.2 GE Healthcare
  8. 7.2.1 GE Healthcare Company Information
  9. 7.2.2 GE Healthcare Business Overview
  10. 7.2.3 GE Healthcare Neurotrophins Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 GE Healthcare Neurotrophins Product Portfolio
  12. 7.2.5 GE Healthcare Recent Developments
  13. 7.3 Merck Serono
  14. 7.3.1 Merck Serono Company Information
  15. 7.3.2 Merck Serono Business Overview
  16. 7.3.3 Merck Serono Neurotrophins Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck Serono Neurotrophins Product Portfolio
  18. 7.3.5 Merck Serono Recent Developments
  19. 7.4 PeproTech
  20. 7.4.1 PeproTech Company Information
  21. 7.4.2 PeproTech Business Overview
  22. 7.4.3 PeproTech Neurotrophins Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 PeproTech Neurotrophins Product Portfolio
  24. 7.4.5 PeproTech Recent Developments
  25. 7.5 Scil Proteins GmbH
  26. 7.5.1 Scil Proteins GmbH Company Information
  27. 7.5.2 Scil Proteins GmbH Business Overview
  28. 7.5.3 Scil Proteins GmbH Neurotrophins Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Scil Proteins GmbH Neurotrophins Product Portfolio
  30. 7.5.5 Scil Proteins GmbH Recent Developments
  31. 7.6 Scil Proteins GmbH
  32. 7.6.1 Scil Proteins GmbH Company Information
  33. 7.6.2 Scil Proteins GmbH Business Overview
  34. 7.6.3 Scil Proteins GmbH Neurotrophins Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Scil Proteins GmbH Neurotrophins Product Portfolio
  36. 7.6.5 Scil Proteins GmbH Recent Developments
  37. 7.7 Lonza Groups
  38. 7.7.1 Lonza Groups Company Information
  39. 7.7.2 Lonza Groups Business Overview
  40. 7.7.3 Lonza Groups Neurotrophins Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Lonza Groups Neurotrophins Product Portfolio
  42. 7.7.5 Lonza Groups Recent Developments
  43. 7.8 Johnson＆Johnson
  44. 7.8.1 Johnson＆Johnson Company Information
  45. 7.8.2 Johnson＆Johnson Business Overview
  46. 7.8.3 Johnson＆Johnson Neurotrophins Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Johnson＆Johnson Neurotrophins Product Portfolio
  48. 7.8.5 Johnson＆Johnson Recent Developments
8 North America
  1. 8.1 North America Neurotrophins Market Size by Type
  2. 8.1.1 North America Neurotrophins Revenue by Type (2021-2032)
  3. 8.1.2 North America Neurotrophins Sales by Type (2021-2032)
  4. 8.1.3 North America Neurotrophins Price by Type (2021-2032)
  5. 8.2 North America Neurotrophins Market Size by Application
  6. 8.2.1 North America Neurotrophins Revenue by Application (2021-2032)
  7. 8.2.2 North America Neurotrophins Sales by Application (2021-2032)
  8. 8.2.3 North America Neurotrophins Price by Application (2021-2032)
  9. 8.3 North America Neurotrophins Market Size by Country
  10. 8.3.1 North America Neurotrophins Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Neurotrophins Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Neurotrophins Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Neurotrophins Market Size by Type
  2. 9.1.1 Europe Neurotrophins Revenue by Type (2021-2032)
  3. 9.1.2 Europe Neurotrophins Sales by Type (2021-2032)
  4. 9.1.3 Europe Neurotrophins Price by Type (2021-2032)
  5. 9.2 Europe Neurotrophins Market Size by Application
  6. 9.2.1 Europe Neurotrophins Revenue by Application (2021-2032)
  7. 9.2.2 Europe Neurotrophins Sales by Application (2021-2032)
  8. 9.2.3 Europe Neurotrophins Price by Application (2021-2032)
  9. 9.3 Europe Neurotrophins Market Size by Country
  10. 9.3.1 Europe Neurotrophins Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Neurotrophins Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Neurotrophins Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Neurotrophins Market Size by Type
  2. 10.1.1 China Neurotrophins Revenue by Type (2021-2032)
  3. 10.1.2 China Neurotrophins Sales by Type (2021-2032)
  4. 10.1.3 China Neurotrophins Price by Type (2021-2032)
  5. 10.2 China Neurotrophins Market Size by Application
  6. 10.2.1 China Neurotrophins Revenue by Application (2021-2032)
  7. 10.2.2 China Neurotrophins Sales by Application (2021-2032)
  8. 10.2.3 China Neurotrophins Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Neurotrophins Market Size by Type
  2. 11.1.1 Asia Neurotrophins Revenue by Type (2021-2032)
  3. 11.1.2 Asia Neurotrophins Sales by Type (2021-2032)
  4. 11.1.3 Asia Neurotrophins Price by Type (2021-2032)
  5. 11.2 Asia Neurotrophins Market Size by Application
  6. 11.2.1 Asia Neurotrophins Revenue by Application (2021-2032)
  7. 11.2.2 Asia Neurotrophins Sales by Application (2021-2032)
  8. 11.2.3 Asia Neurotrophins Price by Application (2021-2032)
  9. 11.3 Asia Neurotrophins Market Size by Country
  10. 11.3.1 Asia Neurotrophins Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Neurotrophins Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Neurotrophins Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Neurotrophins Market Size by Type
  2. 12.1.1 SAMEA Neurotrophins Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Neurotrophins Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Neurotrophins Price by Type (2021-2032)
  5. 12.2 SAMEA Neurotrophins Market Size by Application
  6. 12.2.1 SAMEA Neurotrophins Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Neurotrophins Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Neurotrophins Price by Application (2021-2032)
  9. 12.3 SAMEA Neurotrophins Market Size by Country
  10. 12.3.1 SAMEA Neurotrophins Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Neurotrophins Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Neurotrophins Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Neurotrophins Value Chain Analysis
  2. 13.1.1 Neurotrophins Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Neurotrophins Production Mode & Process
  6. 13.2 Neurotrophins Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Neurotrophins Distributors
  9. 13.2.3 Neurotrophins Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst